Neoadjuvant Chemotherapy Followed by Surgery in Figo Stage IB2, IIA2, and IIB Cervical Cancer—Survival Analysis-Reference-Cited by-同舟云学术

Neoadjuvant Chemotherapy Followed by Surgery in Figo Stage IB2, IIA2, and IIB Cervical Cancer—Survival Analysis

Published:2023-07-19 Issue:3 Volume:21 Page:
ISSN:2363-8397
Container-title:Indian Journal of Gynecologic Oncology
language:en
Short-container-title:Indian J Gynecol Oncolog

Author:

Shanmugam Subbiah^ORCID,Susikar Sujay,Pravenkumar R. R.

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s40944-023-00738-0.pdf

Reference22 articles.

1. Sardi JE, Giaroli A, Sananes C, Ferreira M, Soderini A, Bermudez A, Snaidas L, Vighi S, Gomez Rueda N, di Paola G. Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: the final results. Gynecol Oncol. 1997;67(1):61–9. https://doi.org/10.1006/gyno.1997.4812. (PMID: 9345358).

2. Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 1999;340:1154–61.

3. Souhami L, Gil RA, Allan SE, et al. A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIB carcinoma of the cervix. J Clin Oncol. 1991;9:970–7.

4. Rotman M, Sedlis A, Piedmonte MR, et al. A phase III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. Int J Radiat Oncol Biol Phys. 2006;65:169–76.

5. Linghu H, Xu XR, Mei YY, Tang JY, Tang LD, Sun T. Response of early-stage bulky cervical squamous carcinoma to preoperative adjuvant chemotherapy. Chin Med Sci J. 2004;19(2):116–9.